Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
57,025,350
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
2,212,131
-
Shares change
-
+1,569,417
-
Total reported value, excl. options
-
$15,294,000
-
Value change
-
+$10,883,693
-
Number of buys
-
12
-
Number of sells
-
-1
-
Price
-
$6.90
Significant Holders of Intercure Ltd. - Ordinary Shares, no par value (INCR) as of Q3 2021
13 filings reported holding INCR - Intercure Ltd. - Ordinary Shares, no par value as of Q3 2021.
Intercure Ltd. - Ordinary Shares, no par value (INCR) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,212,131 shares
of 57,025,350 outstanding shares and own 3.88% of the company stock.
Largest 10 shareholders include Ibex Investors LLC (1,356,054 shares), ARK Investment Management LLC (287,671 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (212,500 shares), UBS Group AG (114,220 shares), MARSHALL WACE, LLP (112,947 shares), JANE STREET GROUP, LLC (49,093 shares), GOLDMAN SACHS GROUP INC (40,790 shares), CITADEL ADVISORS LLC (28,242 shares), BANK OF AMERICA CORP /DE/ (5,164 shares), and MORGAN STANLEY (4,600 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.